Shareholder Zhi Ji 2 of Shanghai Shenqi Pharmaceutical Investment Management (600613.SH) has completed the reduction of 1.25% stake.

Shanghai Shenqi Pharmaceutical Investment Management (600613.SH) announced that by February 28, 2025, the company's shareholder Hangzhou Queshi Private Equity Fund Management Co., Ltd. - Queshi Zhi Ji 2 Private Equity Securities Investment Fund (referred to as "Zhi Ji 2") has reduced its holdings of the company's shares by a cumulative 6.6765 million shares, accounting for 1.25% of the company's shares. The time period for this reduction plan has expired, and the reduction plan has been completed.